Invasive extended-spectrum beta-lactamase (ESBL) related infection rates are not influenced by international travel restrictions

Pathology. 2022 Oct;54(6):792-795. doi: 10.1016/j.pathol.2021.11.005. Epub 2022 Feb 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Enterobacteriaceae Infections*
  • Enterobacteriaceae*
  • Humans
  • Travel
  • beta-Lactamases

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases